The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks rise as historic US Fed hike fears ease

Mon, 18th Jul 2022 17:09

(Alliance News) - Stocks in London ended higher on Monday as investors reversed bets over a 100 basis points interest rate increase from the US Federal Reserve.

The Fed's policy-setting Federal Open Market Committee is due to meet July 26 to 27 to debate the next move in its war on inflation. Expectations of a sharper full percentage point hike had grown last week after figures showed the US annual inflation rate raced to 9.1% in June, from 8.6% in May.

However, markets now believe a 75 basis point hike from the US Federal Reserve is the most likely outcome.

Incidentally, a 100 bps hike would be the largest increase since the Fed started directly using overnight interest rates to conduct monetary policy in the early 1990s.

The FTSE 100 index closed up 64.23 points, or 0.9%, at 7,223.24. The FTSE 250 ended up 181.35 points, or 1.0%, at 19,015.15, and the AIM All-Share closed up 11.62 points, or 1.3%, at 885.97.

The Cboe UK 100 ended up 0.7% at 719.53, the Cboe UK 250 closed up 1.1% at 16,557.47, and the Cboe Small Companies ended up 0.6% at 13,165.83.

In European equities, the CAC 40 in Paris ended up 0.9%, while the DAX 40 in Frankfurt finished 0.7% higher.

"European markets have picked up where they left off on Friday with another strong performance, after Fed officials dialled back expectations of a 100 bps rate rise next week. While sentiment today seems a lot more buoyant, one needs to be careful before drawing too many conclusions from two consecutive strong sessions," CMC Markets analyst Michael Hewson commented.

In the FTSE 100, miners ended among the best performers as commodity prices rose on the back of a weaker dollar.

Antofagasta closed up 4.5%, Anglo American up 3.4%, Glencore up 3.2% and Rio Tinto up 2.9%.

At the other end of the large-caps, GSK ended the worst performer, down 19%, after the spin-off of the drugmaker's consumer health arm Haleon took effect.

Separating Haleon had a large impact on the value of GSK. The company could no longer count income or profit from the consumer health business as its own, nor its growth prospects. This meant GSK shares plunged on the day of the demerger.

As such, GSK will conduct a share consolidation in order to counter any drop. This will reduce the number of shares in issue to increase the price of each one and return them to the price before the demerger was completed.

The Haleon separation will take the form of a demerger of at least 80% of GSK's current 68% share of the consumer business to GSK shareholders. The remaining 32% of Consumer Healthcare is held by US drugmaker Pfizer, which will exit its 32% interest in Haleon after the float, though it cannot start doing this until November.

A consolidation of GSK shares will be implemented on Monday, after the market close. The ratio for the consolidation depends on "fluctuations in the volume and price of the GSK shares" on Monday. Haleon shares also will trade in New York as American depository receipts.

Haleon provides consumer healthcare products in five categories: Oral Health, Pain Relief, VMS, Respiratory Health, Digestive Health and Other.

Haleon went straight into the FTSE 100 index, with its shares closing at 314.00p, giving it a market value of around GBP30 billion. GSK's market capitalisation stands at around GBP70 billion. As a result, the lowest ranked FTSE 100 stock based on closing prices on Monday will be demoted to the FTSE 250 to make room for Haleon, index provider FTSE Russell previously said.

In the FTSE 250, Euromoney closed up 9.5% after the business media and events firm accepted a takeover offer from a consortium of Luxembourg-based private equity firm Astorg Asset Management and London-based private equity firm Epiris.

Direct Line lost 13% after the insurer cautioned on "heightened volatility across the UK motor insurance market", adding another warning from London-listed insurers.

"We have seen claims inflation in motor in the first half of 2022 spike above the levels assumed in our pricing. As a result, we are revising our combined operating ratio target range for 2022 to 96% to 98%," Chief Executive Officer Penny James commented.

Direct Line had previously targeted a combined operating ratio range of 93% to 95%. A ratio below 100% indicates an insurer is making underwriting profit. A ratio of 98% would be only barely profitable.

Blue-chip rival Admiral shed 7.8% in a negative read-across.

The dollar was lower across the board. The pound was quoted at USD1.1994 at the London equities close, up sharply from USD1.1853 at the close Friday.

The euro stood at USD1.0167 at the European equities close, sharply higher against USD1.0074 late Friday. The single currency was moving off 20-year lows, having breached parity against the greenback last week as investors eye the European Central Bank's interest rate decision on Thursday.

Against the yen, the dollar was trading at JPY138.17, down from JPY138.56 late Friday.

Stocks in New York were higher at the London equities close as bank earnings season continued in earnest.

The DJIA was up 0.4%, the S&P 500 index up 0.6% and the Nasdaq Composite up 1.1%.

Dow member Goldman Sachs was up 2.5%. The New York City-based bank reported a fall in profit in the second quarter, as it took a chunky credit loss provision, but also saw revenue slump as its Investment Bank recorded a sharp fall in Underwriting income.

Bank of America shares were flat after the bank reported a sharp drop in profit in the second quarter, as the bank set aside credit provisions due to a "dampened" economic outlook, but saw its largest unit record income growth.

Brent oil was quoted at USD105.55 a barrel at the equities close, rising from USD101.57 at the close Friday.

Gold stood at USD1,709.33 an ounce at the London equities close, firm against USD1,704.08 late Friday.

The economic events calendar on Tuesday has UK labour market data at 0700 BST and eurozone inflation readings at 1000 BST.

The UK corporate calendar on Tuesday has interim results from lender Arbuthnot Banking Group and photo booth operator Photo-Me International. There are also trading statements from construction firm Kier Group and international money transfer provider Wise.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.